Company intelligence / Profile preview

Shanghai Ashermed Medical Technology

Shanghai, Shanghai Municipality, Chinaashermed.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Shanghai Ashermed Medical Technology specializes in providing contract research and technical services for the pharmaceutical and medical device industries. The company has over ten years of experience managing marketing projects and clinical studies in oncology and chronic disease areas. It also offers custom system development for hospital projects[1][4]. No direct information on proprietary drug or device programs or clinical results.

Therapeutic areas: OncologyEndocrinologyOtherPsychiatryGastroenterology
Modalities: clinical research services
Industry: Contract Research Organization

Drug pipeline

1 asset

sintilimab

Phase 2

Indications: Squamous non-small cell lung cancer

Beyond the preview

Go deeper on Shanghai Ashermed Medical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Ashermed Medical Technology.

Explore the full profile